According to the latest disclosure from the Hong Kong Stock Exchange, on December 24, Vice President and Executive Director Xie Xin acquired an additional 1 million shares of SINO BIOPHARM (01177) at HK$6.4068 per share, totaling approximately HK$6.4068 million. Following this transaction, Xie Xin's total holdings in the company reached approximately 361 million shares, representing a 1.92% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments